Posts by Fred Schwaller
The “Middle Child” of the Opioid Receptor Family: Targeting the Delta Opioid Receptor as a Promising Treatment Approach for Migraine – A Podcast with Amynah Pradhan
By Fred Schwaller |
Neuroscientist Amynah Pradhan chats about the promise of targeting delta opioid receptors as a way to treat migraine safely and effectively, her recent work on neuronal complexity, and much more.
Migraine Changes the Structure of Neurons in the Brain – and Quickly, Too
By Fred Schwaller |
A new study in mice shows that migraine alters neuronal complexity in pain-processing regions in the brain within hours.
Large Clinical Trial Shows Efficacy and Safety of External Trigeminal Nerve Stimulation for Migraine Treatment
By Fred Schwaller |
A study of more than 500 patients across 10 sites in the US reaches its primary outcomes of pain freedom and resolution of most bothersome symptoms. Does this pave the way for more widespread clinical use of neuromodulation?
A Drug That Boosts Naturally Occurring Opioids Eases Migraine Pain in an Animal Model
By Fred Schwaller |
PL37, which inhibits the enzymes that degrade enkephalins, reduces migraine pain in rats.
Are Schwann Cells the Bad Guys of Migraine Pain?
By Fred Schwaller |
New findings in mice show that CGRP activates Schwann cells to sensitize trigeminal neurons, leading to migraine-like pain.
